CEACAM5 and colorectal carcinoma: Other TCEs have been developed to target different cell-surface proteins including carcinoembryonic antigen-related cell adhesion molecule 5 (CEA) (18, 19), which is highly expressed in CRC and other cancers and is known to drive metastasis (20, 21).